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Abstract
Background: In the Quality in Acute Stroke Care (QASC) trial undertaken in stroke units (SUs) located in New South
Wales (NSW), Australia (2005–2010), facilitated implementation of a nurse-led care bundle to manage fever,
hyperglycaemia and swallowing (FeSS protocols) reduced death and disability for patients with stroke. We aimed to
determine subsequent adherence to the bundled FeSS processes (reflective of the protocols) between 2013 and
2017 in Australian hospitals, and examine whether changes in adherence to these processes varied based on
previous participation in the QASC trial or subsequent statewide scale-up (QASCIP—Quality in Acute Stroke Care
Implementation Project) and presence of an SU.
Methods: Cross-sectional, observational study using self-reported organisational survey and retrospective clinical
audit data from the National Acute Services Stroke Audit (2013, 2015, 2017). Mixed-effects logistic regression was
performed with dependent variables: (1) composite outcome measure reflecting compliance with the FeSS
protocols and (2) individual FeSS processes, including the year of audit as an independent variable, adjusted for
correlation of outcomes within hospital. Separate models including interaction terms between the year of audit and
previous participation in QASC/QASCIP and year of audit and SU were also generated.
Results: Hospital participation included the following: 2013—124 hospitals, 3741 cases; 2015—112 hospitals, 4087
cases; and 2017—117 hospitals, 4192 cases. An 80% increase in the odds of receiving the composite outcome in
2017 compared to 2013 was found (2013, 30%; 2017, 41%; OR 1.8; 95% CI 1.6, 2.0; p < 0.001). The odds of FeSS
adherence from 2013 to 2017 was greater for hospitals that had participated in QASC/QASCIP relative to those that
had not (participated OR 2.1; 95% CI 1.7, 2.7; not participated OR 1.6; 95% CI 1.4, 1.8; p = 0.03). Similar uptake in
adherence was evident in hospitals with and without an SU between 2013 and 2017.
Conclusion: The use of the FeSS protocols within Australia increased from 2013 to 2017 with the inclusion of these
care processes in the National Audit. Greater uptake in hospitals previously involved in QASC/QASCIP was evident.
Our implementation methods may be useful for other national initiatives for improving access to evidence-based
practice.
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Background
Similar to other areas of healthcare, the need to reduce
the evidence-practice gap remains a challenge in stroke
management. Within Australian hospitals, there is a
marked variation in the quality of stroke care provided
[1, 2]. For example, access to stroke units ranges from
0–98% and the provision of thrombolysis from 0–20%
[2], despite both of these processes being recommended
in national guidelines [3]. It is well recognised that there
are a number of challenges to embedding evidence into
routine clinical practice. Translating research knowledge
into practice requires clinicians to change behaviour [4],
which can be a difficult and lengthy process, and is usu-
ally influenced by a wide range of factors [5]. No single
approach is successful for all healthcare settings. Strat-
egies that have taken into account contextual issues and
barriers and facilitators to their implementation have
had success in changing clinician behaviours and closing
the evidence-practice gap [4–7].
Very few evidence-based nursing interventions exist
for stroke. The Quality in Acute Stroke Care (QASC)
trial was a complex healthcare intervention, involving
multi-disciplinary supported nurse-initiated protocols
for monitoring and managing of fever, hyperglycaemia
(high sugar) and swallow dysfunction (FeSS protocols)
post-stroke. This cluster randomised controlled trial was
undertaken in 19 stroke units in New South Wales
(NSW), Australia, throughout 2005–2010 [8]. The inter-
vention consisted of barrier identification, multidisciplin-
ary teamwork, educational outreach, local adaption, use
of site champions and reminders [8]. An improvement
in the quality of care provided [9], a 16% reduction in
death and disability 90 days following stroke [8] and po-
tential long-term survival benefits were shown [10]. Fol-
lowing on, the FeSS protocols were systematically
introduced with training and the other strategies into all
36 stroke services (31 with a stroke unit) within one
Australian state, NSW. The Quality in Acute Stroke
Care Implementation Project (QASCIP) was conducted
during 2013–2014, to evaluate the implementation strat-
egies used in the original trial to promote ‘scale up and
spread’ of this proven intervention. Improvements in ad-
herence to the three FeSS protocols were found,
demonstrating the successful statewide scale-up of this
complex, quality-improvement intervention [6].
With the positive outcomes, individual indicators
reflecting the bundled care processes in the FeSS proto-
cols were included in the voluntary, biennial, National
Stroke Audit programme (Australia) in 2013. This
allowed the individual care processes, not already part of
the audit (e.g. fever and glycaemia processes) to be mon-
itored, nationally. No further national, systematic effort
was made to implement the specific QASC intervention.
However, uptake of the FeSS protocols may have been
indirectly supported via this audit and feedback process,
which was not part of the original QASC/QASCIP inter-
vention. Moreover, the data from the National Audit
were not specifically bundled as ‘FeSS processes’ in re-
ports back to hospitals, which included a summary of
some of these indicators.
Implementation of care bundles, which comprise of a
small number of evidence-based interventions, that
when implemented together, improve patient outcomes
[11], have been used to improve care in a variety of
health areas including chronic obstructive pulmonary
disease, ventilator-associated pneumonia [12], catheter-
related blood stream infections [13], and delirium [14].
Inclusion of these bundles in national audits [15] and
registries [16, 17] have been used to effect.
The level of translation of the FeSS protocols into
standard stroke care across Australia, beyond the hospi-
tals involved in QASC and QASCIP, is unknown. The
aim of this study was to determine adherence to specific
FeSS processes of care (reflective of the protocols) be-
tween 2013 and 2017 in Australian hospitals delivering
acute stroke care as a case study to highlight evidence
translation in stroke. Secondary aims included establish-
ing whether changes in adherence over time varied by
participation in the QASC trial or QASCIP and in hospi-
tals with and without a stroke unit (SU). We also wanted
to compare adherence to the individual FeSS processes
in the 2017 National Audit to results of QASC and
QASCIP.
Methods
Cross-sectional data were used in this observational study,
from hospitals participating in the biennial National
Stroke Audit–Acute Services programme (Australia) dur-
ing 2013, 2015 and 2017 [18]. The programme entails a
self-reported organisational survey and a retrospective
clinical medical record audit. The survey captures infor-
mation on organisational features of the service compris-
ing bed numbers, service characteristics including the use
of management protocols for fever and available re-
sources. The clinical medical record audit is performed by
trained data abstractors from each hospital. The first 40
consecutive case records of patients with a primary diag-
nosis of stroke (ICD-10 codes: I61, I62.9, I63, I64) are
audited from admissions over a 6-month period starting
in June (the previous year). For example, data included in
the 2013 audit reflected patient admissions from 2012.
Data are captured on a specifically designed web tool
using standardised procedures. Patient demographic char-
acteristics, adherence to processes of care, and in-hospital
outcomes are collected [19]. Up to five cases from hospi-
tals are re-audited by a second abstractor to determine the
inter-rater reliability.
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Data collection
Nine indicators of adherence to the FeSS protocols were
developed and included in the Stroke Foundation audit
programme in 2013 after the publication of the positive
results of the QASC trial (herein referred to as FeSS pro-
cesses). These were also collected in QASCIP. Other
than processes relating to swallow function (prior to oral
intake), no other indicators related to the FeSS processes
were included in the National Audit prior to 2013. After
the 2013 audit, changes were made by the Stroke Foun-
dation to reduce data burden and align questions with
the current Acute Stroke Services Framework [20] and
the Acute Stroke Clinical Care Standards [21]. Thus, not
all processes from the FeSS protocols collected in the
2013 audit were collected in 2015/2017. Three processes
not collected related to the monitoring of fever and
hyperglycaemia in the first 3 days of the admission, with
all treatment-related processes remaining consistent
(Table 1). Figure 1 displays the timeline of data collec-
tion and publications for QASC, QASCIP and the
National Audits.
Statistical analysis
Data from hospitals participating in any audit were in-
cluded in analyses. ‘Not documented’ and ‘unknown’ re-
sponses to the categorical questions related to adherence
were assumed to be negative and included in the denomin-
ator. Only the six FeSS processes common in all three au-
dits were included. As with the earlier trial, the process of
care outcome was a derived composite measure, which
reflected compliance to all fever, hyperglycaemia and swal-
low processes (see Table 1). Decision rules around the
composite outcome were consistent with QASCIP, where
applicable [6]. Adherence to the individual FeSS processes
was reported in order to assess uptake into clinical practice
of specific components. Characteristics of patients and hos-
pitals were compared across the three audits using the chi-
square test for categorical variables and the Kruskal-Wallis
test for continuous variables.
To assess whether adherence to the FeSS processes
changed over time, and if so, between which years,
separate logistic regression models, which included
the year of the audit, were generated for the com-
posite outcome and each individual process. A
mixed-effects model was used to adjust for potential
correlation of outcomes within hospitals.
For the composite outcome, we also generated add-
itional models which included an interaction term be-
tween year of audit and (a) previous participation in
QASC or QASCIP and (b) presence of an SU, to deter-
mine if adherence to the FeSS processes over time dif-
fered by previous involvement in QASC/QASCIP or
presence of a stroke unit. The p values for the
interaction term were used to determine whether the
factor was associated with a change in adherence. We
did not adjust for patient characteristics in our primary
analyses since the composite outcome was relevant to all
patients, and it is assumed that all eligible patients
should receive the recommended care processes regard-
less of stroke severity or other factors. We also per-
formed sensitivity analyses where patient characteristics
and organisational factors with p < 0.1 on univariable
analyses and variables with clinical importance (such as
age and sex) were included in the modelling for adher-
ence to the individual processes and the composite
outcome.
The level of significance for all statistical tests was
p < 0.05. Adjusted odds ratios and 95% confidence
intervals (CIs) are presented for all multivariable re-
sults. Data were analysed using Stata SE 15.0 [22].
Post hoc power calculations provided evidence that
the study had at least 80% power to detect absolute dif-
ferences in adherence to the composite outcome be-
tween audit years of 4.5–6.5%, with a 5% significance
level. This calculation assumed an average of 30–36
audits per hospital, intraclass correlation coefficients of
0.02 to 0.1, consistent with previous work [8, 23], result-
ing in design effects of 2–4 due to the correlation of out-
comes within hospitals [24].
Results
A total of 124 hospitals provided 3741 cases to the 2013
audit, with 112 hospitals involved in 2015 (4087 cases), and
in 2017, 4192 cases were provided by 117 hospitals. In
2013, 17 hospitals providing data to the audit had partici-
pated in QASC, contributing 620 cases (17%). In 2015, 32
hospitals had either participated in QASC or QASCIP
(1158 cases, 28%), and in 2017, this included 35 hospitals
(1280 cases, 31%).
The majority of participating hospitals in the clinical
audits had an SU (2013, 87; 2015, 88; 2017, 94). How-
ever, a total of 1930 patients were still treated in a hos-
pital without an SU in the audits (2013, 673; 2015, 664;
2017, 593).
The other organisational characteristics of hospitals
participating in each audit are presented in Table 2.
There was no difference in the proportion of participat-
ing hospitals that had an SU, a stroke clinical care path-
way or regular stroke multidisciplinary team meetings
across the three audit periods. Statistically significant in-
creases over time were evident in the proportion of hos-
pitals reporting the use of protocols for fever (2013 77%,
2017 92%; p < 0.001), hyperglycaemia (2013 81%, 2017
91%; p = 0.009) and swallow dysfunction (2013 85%,
2017 97%; p = 0.001). The median age of participants
across all cohorts was 76 years, 55% were male, and 25%
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had a history of diabetes. The proportion of patients pre-
senting with an ischaemic stroke varied significantly
across time; however, differences were small (2013 77%,
2015 76%, 2017 80%; p < 0.001). There was a reduction
in the severity of stroke across the audits, as indicated by
differences in the proportion with arm weakness, and an
inability to walk on admission, and incontinence within
72 h reported from the 2013 to 2017 audits (please see
Additional file 1).
The proportion of patients with reported fever and high
glucose levels in the first 48 h of admission decreased sig-
nificantly over time, although changes were small (fever—
2013 15%, 2015 12%, 2017 11%, p < 0.001; high glucose—
2013 19%, 2015 17%, 2017 16%, p = 0.003) (data not
shown). Compared with 2013 (30%), adherence to the
composite outcome improved in 2017 (41%) (Table 3).
With multivariable analyses, we found an 80% overall in-
crease in the odds of receiving all FeSS processes (com-
posite outcome) in 2017 compared to 2013 (OR 1.8; 95%
CI 1.6, 2.0; p < 0.001), with a small change between 2013
and 2015. Adherence to individual fever and hypergly-
caemia processes and most individual swallow compo-
nents (except for swallow treatment) improved from 2013
to 2017, with greater improvements evident between 2015
and 2017, compared to 2013–2015 (Table 3).
In 2013, adherence to the composite outcome was similar
for hospitals that had participated in QASC and those who
had not (participated 31%, not participated 30%). The
Table 1 Comparison of processes collected in QASC, QASCIP and National Audits, with outline of FeSS processes included for
analyses
Processes included in the FeSS protocols QASC QASCIP National Audits Processes included in the current study and definition for
analysis2013 2015 2017
Fever
Temperature recorded at least four times
on day 1, day 2 and day 3a
✓ ✓ ✓ × ×
Received paracetamol within 1 h of the
first febrile event (recorded in first 72 h)
✓ ✓ ✓ ✓ ✓ ✓
F1 Overall fever treatment Patients without fever classified as receiving appropriate fever
treatment
Hyperglycaemia
Formal venous blood glucose level
recorded in the ED
✓ ✓ ✓ × ×
Finger prick glucose recorded at least
four times on day 1, day 2 and day 3a
✓ ✓ ✓ × ×
Insulin within 1 h if glucose > 10mmol/
Lb (recorded in the first 72 h)
✓ ✓ ✓ ✓ ✓ ✓
G1 Overall hyperglycaemia treatment Patients without high glucose classified as receiving
appropriate hyperglycaemia treatment
Swallow
S1 Swallow screen or swallow assessment
by speech pathologist within 24 h of
admission
✓ ✓ ✓ ✓ ✓ ✓
S2 Swallow screen or assessment before
food or drink
✓ ✓ ✓ ✓ ✓ ✓
S3 Swallow screen or assessment before
oral medications
✓ ✓ ✓ ✓ ✓ ✓
S4 Overall swallow monitoring Met all of S1, S2 and S3 (total cohort)
S5 Swallow assessment by speech
pathologist if failed swallow screen
✓ ✓ ✓ ✓ ✓ ✓
Those who did not fail swallow screen or did not receive the
screen were classified as receiving appropriate swallow
treatment
S6 Overall swallow monitoring and
treatment
If monitoring elements S1, S2, S3 and treatment element S5
all met
Composite outcome
All fever, sugar and swallow elements
Met all of F1, G1 and S6
FeSS fever, sugar swallow; QASC Quality in Acute Stroke; QASCIP Quality in Acute Stroke Implementation Project; ED emergency department
aQuestion was asked individually for each of day 1, day 2 and day 3
bFinger prick glucose greater than 10 mmol/L (in QASC used 11 mmol/L, with changes reflecting recent updates in Australian guidelines)
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change in odds of adherence over time differed by partici-
pation (p < 0.001 for overall interaction term) and was gen-
erally larger for hospitals that had been involved with
QASC/QASCIP compared to others in Australia (Table 4).
The odds ratio of adherence for 2017 relative to 2013 was
2.1 (95% CI 1.7, 2.7) for hospitals that had previously partic-
ipated and 1.6 (95% CI 1.4, 1.8; p = 0.03) for those that had
not participated (Fig. 2). For comparable individual pro-
cesses, adherence at hospitals that had previously partici-
pated in QASC/QASCIP completing the 2017 audit was
found to be similar or improved against the QASCIP post-
implementation cohort, particularly for fever and hypergly-
caemia treatment processes (please see Additional file 2).
Favourable improvements were also evident in hospitals in
NSW or elsewhere in Australia that had not previously par-
ticipated in QASC/QASCIP.
Changes in adherence to the composite outcome varied
overall for hospitals with and without an SU (p < 0.001 for
overall interaction term). Overall, there was no difference
in odds of improvement evident between 2013 and 2017
(p = 0.6) (Fig. 3). However, adherence to the composite
outcome in SU hospitals was still significantly greater than
in those without an SU (2017—SU, 43%; non-SU 29%).
Results of the sensitivity analyses including patient
characteristics and organisational factors in the multivar-
iable modelling were consistent with our primary results
(please see Additional files 3 and 4).
Discussion
Results of our study show there has been increased uptake
of the main FeSS processes across Australia over a 4-year
period, with inclusion of these processes in the National
Fig. 1 Timeline of data collection and publications for QASC, QASCIP and National Audits
Table 2 Organisational characteristics of hospitals participating in the National Audits
Organisational characteristics of hospitals participating in the clinical audit 2013 Audit,
N = 124
2015 Audit,
N = 112
2017 Audit,
N = 117
p valuea
Dedicated stroke unit 87 (70%) 88 (79%) 94 (80%) 0.14
Clinical care pathway for managing stroke 94 (76%) 93 (83%) 99 (85%) 0.18
Regular stroke multidisciplinary team meetings 115 (93%) 106 (95%) 107 (91%) 0.64
Agreed management (including assessment/monitoring) protocols for:
Fever 95 (77%) 103 (92%) 108 (92%) < 0.001
Hyperglycaemia 100 (81%) 104 (93%) 106 (91%) 0.009
Swallow dysfunction 106 (85%) 107 (96%) 114 (97%) 0.001
aFrom chi-square test
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Audit from 2013. Further, similar results were evident in
both our primary and sensitivity analyses with adjustment
for patient and organisational characteristics. These results
are of particular interest in the wider context of stroke care
in Australia, given that adherence to many other processes
over the same time period has either stagnated or shown
only minimal improvements [1]. These results are also rele-
vant to other countries with similar health system resources
to Australia, given the dearth of evidence-based nurse-led
interventions for stroke [3], a leading cause of death and
disability globally [25].
Translating evidence from clinical trials into routine
clinical practice is inherently difficult [26], which can
detrimentally affect patient care and outcomes [27].
Often, implementation activities are focused on short-
term actions and effects [28]. Limited research has eval-
uated sustainability and uptake of evidence into practice
post-implementation initiatives [29, 30]. Within the lit-
erature, various methods have been used to encourage
routine adoption of evidence-based care, particularly
related to care bundles, in clinical practice. In the review
by Borgert and colleagues [15], it was demonstrated that
audit and feedback was one of the most frequently used
strategies to implement care bundles. Mandatory report-
ing [31], removal of perverse incentive payments [32]
and more specific quality improvement programmes fo-
cused on combinations of building leadership, shared
learning, mentoring and on-going measurement have
also been used with effect [13, 33].
Adherence to the bundled care processes after the ini-
tial focused implementation efforts is often not main-
tained, or improved as in our study. Helmick and
colleagues did report a small increase in compliance in
ventilator-associated pneumonia and catheter-related
bloodstream infection bundles after initial focused ef-
forts to implement these into routine care [34]. Alterna-
tively, Ferrer et al. reported that adherence to a sepsis
care bundle returned to baseline 1 year after a national
education programme was ceased [35]. This is also in
line with a recent systematic review where adherence to
guideline recommendations 1 year post-implementation
with no further systematic implementation activities re-
duced in approximately 50% of studies [29]. However,
sustained improvements in hospital care practices have
been described from 6 to 36 months post-implementa-
tion in other conditions [36, 37]. Within stroke, there is
variability. Sustained improvement in the provision of
discharge care processes was evident 9 months post-im-
plementation in one study [7]; however, in another
multi-centre trial, improvements after the initial quality
improvement effort were not sustained at 12 months
[38]. Given the difficulties and variability in achieving
knowledge translation and the considerable length of
time it takes to embed evidence into standard practice
[39], the results from the current study are notable indi-
cating scale up and spread ‘at pace’ and provide insight
into knowledge transfer in this context.
Table 4 Changes in adherence to composite outcome over time (2013–2017) by participation in QASC/QASCIP and the presence of
a stroke unit
2015 vs 2013a 2017 vs 2015a 2017 vs 2013a
OR (95% CI) p valueb OR (95% CI) p valueb OR (95% CI) p valueb
Participation in QASC/QASCIP
Participatedc 1.2 (0.95, 1.6) 0.4 1.7 (1.4, 2.0) 0.4 2.1 (1.7, 2.7) 0.03
Not participatedc 1.1 (0.93, 1.2) 1.5 (1.4, 1.7) 1.6 (1.4, 1.8)
Presence of a stroke unit
Yes 1.0 (0.93, 1.2) 0.051 1.7 (1.5, 1.8) 0.09 1.7 (1.5, 1.9) 0.6
No 1.4 (1.04, 1.9) 1.4 (1.0, 1.8) 1.9 (1.4, 2.6)
Dependent variable is adherence to composite outcome measure; independent variables include interaction term between year/participation QASC/QASCIP or
year/stroke unit presence, adjusted for correlation within hospital. OR Odds Ratio, CI Confidence Interval
aReference year
bFor the interaction term
cParticipated in QASC or QASCIP
Fig. 2 Change in adherence to the composite outcome in 2013
compared to 2017: by previous participation in QASC/QASCIP
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The use of ‘audit and feedback’ as an intervention in
itself has been shown to be effective in improving
healthcare delivery, with a median absolute improve-
ment in the care of 4% (first quartile + 0.5%, third quar-
tile + 16%) reported in a previous systematic review [40].
The data presented in our study represents two audit
and feedback cycles of acute services. The feedback pro-
vided by the Stroke Foundation as part of the National
Audit programme was relatively passive. No direction
about implementing change was provided; rather, it was
more around ‘monitoring’ care being delivered. This in-
cluded generating and distributing a national report with
aggregated data for individual care processes (e.g. not
presented specifically as a FeSS care bundle) and individ-
ual site reports for all hospitals participating in each
cycle. The overall net change of 10–14% improvement
in many FeSS processes from our results compares
favourably to the upper limits reported in previous stud-
ies of audit and feedback programmes [40]. These results
highlight the potential benefits of integrating audit and
feedback into exiting national registry and audit pro-
grammes. Consideration of how to actively provide feed-
back may help to consolidate these results further [41].
Adherence to the composite outcome in 2013 was
similar in hospitals that participated in QASC and those
that did not. Analyses were not conducted to examine
differences by QASC group allocation to control or
intervention, which could have diluted the effect of ‘par-
ticipation’ in 2013. Overall, change in adherence to the
composite outcome from 2013 to 2017 was greater in
hospitals that had participated in the previous QASC/
QASCIP interventions, where active dissemination of
the FeSS processes occurred via workshops, protocols
and the use of local clinical champions. In addition to
the ‘audit and feedback’ implementation strategy of in-
clusion of related processes in the National Audit, other
factors may have influenced the uptake further. These
include publicity related to the original trial, conference
presentations or publications of the QASC or QASCIP
results. Additionally, the protocols and implementation
strategies used in QASC were freely available to down-
load online, both locally and internationally. While clini-
cians from 21 countries downloaded the resource, self-
report of successful implementation resulting from this
method alone was limited [42]. However, the lack of sys-
tematic data collected on the processes of care in differ-
ent countries means we cannot objectively assess this.
In Australia, recent estimates indicate that only 75% of
services providing acute stroke care have an SU [1].
Therefore, it was of interest to examine the care pro-
vided in hospitals without an SU related to the FeSS pro-
cesses. While the absolute difference in adherence to the
composite outcome between SU and non-SU hospitals is
clear (2017 SU, 43%; non-SU, 29%), there was no differ-
ence in improved adherence between 2017 and 2013. Al-
though it may be reasonable to assume that hospitals
with an SU were already adhering to FeSS processes
[43], improvements seen in non-SU hospitals may have
also potentially been influenced by the lower baseline
performance in non-SU hospitals [38]. In addition, the
inclusion of the five non-SU NSW hospitals in the QAS-
CIP study may have also affected these results. Although
non-SU hospitals were few, there appears to be infiltra-
tion of the organisational processes involved in deliver-
ing these aspects of care more widely in all hospitals
delivering acute stroke care.
Even considering the improvements in adherence to
the composite outcome over time, a sizable evidence-
practice gap remains. Only 41% received all FeSS pro-
cesses (composite outcome) in 2017, with over half of
those patients with fever and 3 in 5 with high glucose
not receiving timely paracetamol and insulin, respect-
ively. These findings are in line with a recent study
where authors demonstrated sub-optimal fever and glu-
cose management in stroke centres in the USA [44]. In
addition, over a third of patients were still receiving oral
medication/food/fluids prior to swallow screening, which
is greater than that reported from recent data as part of
the UK Sentinel Stroke National Audit Programme (26%
did not get a swallow screen in 4 h) [16]. In view of the
evidence demonstrating short and long-term improve-
ment in patient outcomes associated with adherence to
the FeSS processes [8, 10], an ongoing focus on reducing
variation in care around these processes is necessary. Al-
though the need for control of fever and hyperglycaemia
have been made internationally [45], more stringent rec-
ommendations based on results of the QASC trial have
since been included in national and international stroke
guidelines [3, 46]. While adherence to some individual
FeSS processes is measured in international audit pro-
grammes and registries [16, 17], to our knowledge, not
Fig. 3 Change in adherence to the composite outcome in 2013
compared to 2017: by presence of a stroke unit
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all FeSS processes are captured in the same way as the
original FeSS protocols outline. Therefore, it is difficult
to generalise results related to the composite outcome to
other countries. Other countries should be encouraged
to collect data on FeSS process to provide important in-
formation on the effects of translation.
Strengths of the study include the large comprehensive
nationally representative dataset and the use of a na-
tional data dictionary to reduce reporting bias and en-
hance the reliability of data collection. A limitation is
that the composite outcome measure derived is different
to that reported in the initial QASC trial [8], as not all
the original FeSS monitoring processes were collected in
subsequent audits. Changes primarily reflected efforts to
reduce data burden for clinicians (please see Additional
file 5). Even though direct comparisons with the com-
posite measure are not possible, encouragingly, the ad-
herence to other individual FeSS processes was found to
be comparable or even improved against the QASCIP
post-implementation cohort [6]. Limitations to the use
of composite measures have been reported [47]. How-
ever, our methods to negate the influence of missing
data with decision rules to ensure all patients were eli-
gible to receive all processes in the measure and in-built
logic checks in the data tool could address some of these
concerns.
The aim of this study was not to provide an overview
of improvements in adherence to the wider stroke evi-
dence-base. In Australia, this is reported on biennially in
the National Stroke Audit [1] and from the Australian
Stroke Clinical Registry [2]. Rather, we chose to focus on
uptake of the FeSS processes. This is an area not previ-
ously reported on, and related to a proven evidence-
based nurse-initiated intervention. Investigating any as-
sociation with changes in patient outcomes and im-
provements in FeSS processes was beyond the scope of
this study, but an area of interest for future work.
Another limitation is the cross-sectional nature of a
retrospective audit, with up to 40 cases, which only pro-
vides a snapshot of what is occurring over multiple audits
and at each hospital. The audit data collection can also be
influenced by documentation and responder bias. How-
ever, the web tool used for data entry ensured mandatory
responses to questions, and the proportion of ‘not docu-
mented’ responses for process questions was similar over
the audits, lending more confidence that the changes seen
reflected improved care rather than improved documenta-
tion. Reliability checks involving repeated audits were per-
formed to address this. Previous inter-reliability reports of
indicators relating to the FeSS processes provided evi-
dence of substantial agreement [6].
This study provides an example of the benefits of sec-
ondary use of data. As such, biases in retrospective data
abstraction and results were not affected by prior
knowledge of the study’s hypotheses. Inclusion of FeSS
processes prior to 2013 was limited to swallow-related
indicators that were not directly comparable to the pro-
cesses included in the FeSS protocols. Therefore, no na-
tional baseline measure was available to determine
potential secular trends in changes in adherences to
these processes. Comparisons from 2013 to 2017 for
some variables were also potentially influenced by add-
itional changes to questions and responses between the
2013 and 2015 audit. Every effort was undertaken to en-
sure only comparable variables were included. Import-
antly, minimal changes were made between 2015 and
2017; therefore, these data provide a strong basis to as-
sess adherence in future audits. The next acute audit in
2019 will provide important data to assess if there is a
stronger uptake of the FeSS processes. While informa-
tion related to swallow processes has been included in
national guidelines since 2007 [48], recommendations
related to the fever and hyperglycaemia FeSS protocols
have now been included in the recently released 2017
national guidelines [3]. Therefore, the next audit will
also provide stronger indirect evidence as to the impact
of these new guideline recommendations.
Conclusion
Increased adherence to the FeSS processes has occurred
in Australia from 2013 to 2017 since the inclusion of
these processes in the National Audit. Greater improve-
ments were evident in hospitals where active exposure
to the original intervention occurred. Further improve-
ment in adherence to the FeSS processes is still required,
but our implementation methods may be used in other
translation initiatives, potentially beyond stoke care.
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